ArticleOncotarget2019

Therapeutic potential of nimotuzumab PEGylated-maytansine antibody drug conjugates against EGFR positive xenograft.

Siddesh V Hartimath et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.